SYROS PHARMACEUTICALS INC (SYRS)
US87184Q2066 - Common Stock
ChartMill assigns a Buy % Consensus number of 76% to SYRS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.71. This target is 4562.6% above the current price.
SYRS was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about SYRS.
In the last month the buy percentage fell by 6 points. So the trust of analysts is decreasing.
SYRS was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-13 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-11-13 | Brookline Capital | Downgrade | Buy -> Hold |
| 2024-11-13 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-11-13 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-11-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-13 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-08-13 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-08-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-03 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-03 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-08-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-11 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-05-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-03 | Oppenheimer | Maintains | Outperform |
| 2023-03-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-05 | Piper Sandler | Maintains | Overweight |
| 2022-11-15 | JMP Securities | Maintains | Market Outperform |
| 2022-11-15 | Oppenheimer | Maintains | Outperform |
| 2022-11-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-10 | Oppenheimer | Maintains | Outperform |
| 2022-07-12 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-17 | Alliance Global Partners | Maintains | Buy |
| 2022-05-17 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-23 | Roth Capital | Maintains | Buy |